Filters: Keyword is Opiate Substitution Treatment [Clear All Filters]
"HIV treatment outcomes among HIV-infected, opioid-dependent patients receiving buprenorphine/naloxone treatment within HIV clinical care settings: results from a multisite study." Journal of acquired immune deficiency syndromes (1999) 56 Suppl 1 (2011): S22-32. Abstract
"Attitudes toward opioid substitution therapy and pre-incarceration HIV transmission behaviors among HIV-infected prisoners in Malaysia: implications for secondary prevention." Drug and alcohol dependence 116, no. 1-3 (2011): 151-7. Abstract
"Group-based strategies for stress reduction in methadone maintenance treatment: what do patients want?" Journal of addiction medicine 5, no. 3 (2011): 181-7. Abstract
"Use of conventional, complementary, and alternative treatments for pain among individuals seeking primary care treatment with buprenorphine-naloxone." Journal of addiction medicine 6, no. 4 (2012): 274-9. Abstract
"Conventional and unconventional treatments for stress among methadone-maintained patients: treatment willingness and perceived efficacy." The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions 20, no. 2 (2011): 137-42. Abstract
"Developing a modified directly observed therapy intervention for hepatitis C treatment in a methadone maintenance program: implications for program replication." The American journal of drug and alcohol abuse 38, no. 3 (2012): 206-12. Abstract
"Lessons from Tanzania on the integration of HIV and tuberculosis treatments into methadone assisted treatment." The International journal on drug policy 25, no. 1 (2014): 22-5. Abstract
"A review of pharmacological interactions between HIV or hepatitis C virus medications and opioid agonist therapy: implications and management for clinical practice." Expert review of clinical pharmacology 6, no. 3 (2013): 249-69. Abstract
"Investigation of the interactions between methadone and elvitegravir-cobicistat in subjects receiving chronic methadone maintenance." Antimicrobial agents and chemotherapy 57, no. 12 (2013): 6154-7. Abstract
"The marketing of methadone: how an effective medication became unpopular." The International journal on drug policy 24, no. 6 (2013): e89-90.
"Participant characteristics and HIV risk behaviors among individuals entering integrated buprenorphine/naloxone and HIV care." Journal of acquired immune deficiency syndromes (1999) 56 Suppl 1 (2011): S14-21. Abstract
"HIV testing and sexual risk reduction counseling in office-based buprenorphine/naloxone treatment." Journal of addiction medicine 7, no. 6 (2013): 410-6. Abstract
"Human immunodeficiency virus testing practices among buprenorphine-prescribing physicians." Journal of addiction medicine 6, no. 2 (2012): 159-65. Abstract
"The Physician Clinical Support System-Buprenorphine (PCSS-B): a novel project to expand/improve buprenorphine treatment." Journal of general internal medicine 25, no. 9 (2010): 936-41. Abstract
"Drug treatment outcomes among HIV-infected opioid-dependent patients receiving buprenorphine/naloxone." Journal of acquired immune deficiency syndromes (1999) 56 Suppl 1 (2011): S33-8. Abstract
"Integration of buprenorphine for substance-abuse treatment by HIV care providers." Journal of acquired immune deficiency syndromes (1999) 56 Suppl 1 (2011): S1-2.
"Pain catastrophizing and pain coping among methadone-maintained patients." Pain medicine (Malden, Mass.) 12, no. 1 (2011): 79-86. Abstract
"High rates of police detention among recently released HIV-infected prisoners in Ukraine: implications for health outcomes." Drug and alcohol dependence 133, no. 1 (2013): 154-60. Abstract
"Improving adherence to HIV quality of care indicators in persons with opioid dependence: the role of buprenorphine." Journal of acquired immune deficiency syndromes (1999) 56 Suppl 1 (2011): S83-90. Abstract
"Improved quality of life for opioid-dependent patients receiving buprenorphine treatment in HIV clinics." Journal of acquired immune deficiency syndromes (1999) 56 Suppl 1 (2011): S39-45. Abstract
"Rifampin, but not rifabutin, may produce opiate withdrawal in buprenorphine-maintained patients." Drug and alcohol dependence 118, no. 2-3 (2011): 326-34. Abstract
"The role of the Chinese police in methadone maintenance therapy: a literature review." The International journal on drug policy 24, no. 6 (2013): e25-34. Abstract
"Challenges to implementing opioid substitution therapy in Ukrainian prisons: Personnel attitudes toward addiction, treatment, and people with HIV/AIDS." Drug and alcohol dependence 148 (2015): 47-55. Abstract
"Effectiveness and feasibility study of routine HIV rapid testing in an urban methadone maintenance treatment program." The American journal of drug and alcohol abuse 39, no. 4 (2013): 247-51. Abstract
"The impact of cocaine use on outcomes in HIV-infected patients receiving buprenorphine/naloxone." Journal of acquired immune deficiency syndromes (1999) 56 Suppl 1 (2011): S54-61. Abstract
"Current and potential pharmacological treatment options for maintenance therapy in opioid-dependent individuals." Drugs 72, no. 2 (2012): 217-28. Abstract
"Implementation and Operational Research: Linkage to Care Among Methadone Clients Living With HIV in Dar es Salaam, Tanzania." Journal of acquired immune deficiency syndromes (1999) 69, no. 2 (2015): e43-8. Abstract
"The BHIVES collaborative: organization and evaluation of a multisite demonstration of integrated buprenorphine/naloxone and HIV treatment." Journal of acquired immune deficiency syndromes (1999) 56 Suppl 1 (2011): S7-13. Abstract
"Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: a 2-phase randomized controlled trial." Archives of general psychiatry 68, no. 12 (2011): 1238-46. Abstract
"Integration of buprenorphine/naloxone treatment into HIV clinical care: lessons from the BHIVES collaborative." Journal of acquired immune deficiency syndromes (1999) 56 Suppl 1 (2011): S68-75. Abstract
"Implementing methadone maintenance treatment in prisons in Malaysia." Bulletin of the World Health Organization 91, no. 2 (2013): 124-9. Abstract
